| Microneedle-based vaccines MR Prausnitz, JA Mikszta, M Cormier, AK Andrianov Vaccines for Pandemic Influenza, 369-393, 2009 | 361 | 2009 |
| Gas-filled polymeric microbubbles for ultrasound imaging S Cohen, AK Andrianov, M Wheatley, HR Allcock, RS Langer US Patent 5,487,390, 1996 | 214 | 1996 |
| Polymeric carriers for oral uptake of microparticulates AK Andrianov, LG Payne Advanced drug delivery reviews 34 (2-3), 155-170, 1998 | 204 | 1998 |
| Poly [di (carboxylatophenoxy) phosphazene] is a potent adjuvant for intradermal immunization AK Andrianov, DP DeCollibus, HA Gillis, HH Kha, A Marin, MR Prausnitz, ... Proceedings of the national academy of sciences 106 (45), 18936-18941, 2009 | 174 | 2009 |
| Polyphosphazenes for biomedical applications KA Andrianov John Wiley & Sons, 2009 | 165* | 2009 |
| Poly [di (carboxylatophenoxy) phosphazene](PCPP) is a potent immunoadjuvant for an influenza vaccine LG Payne, SA Jenkins, AL Woods, EM Grund, WE Geribo, JR Loebelenz, ... Vaccine 16 (1), 92-98, 1998 | 147 | 1998 |
| Protein release from polyphosphazene matrices AK Andrianov, LG Payne Advanced drug delivery reviews 31 (3), 185-196, 1998 | 141 | 1998 |
| Synthesis and biologically relevant properties of polyphosphazene polyacids AK Andrianov, YY Svirkin, MP LeGolvan Biomacromolecules 5 (5), 1999-2006, 2004 | 140 | 2004 |
| Poly [di (sodium carboxylatoethylphenoxy) phosphazene](PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens G Mutwiri, P Benjamin, H Soita, H Townsend, R Yost, B Roberts, ... Vaccine 25 (7), 1204-1213, 2007 | 126 | 2007 |
| Method for making hydrophobic polymeric microparticles AK Andrianov, RS Langer US Patent 5,500,161, 1996 | 123 | 1996 |
| Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity AK Andrianov, A Marin, BE Roberts Biomacromolecules 6 (3), 1375-1379, 2005 | 115 | 2005 |
| Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions AK Andrianov, J Chen, LG Payne Biomaterials 19 (1-3), 109-115, 1998 | 113 | 1998 |
| Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes BS Powell, AK Andrianov, PC Fusco Clinical and experimental vaccine research 4 (1), 23, 2015 | 110 | 2015 |
| Synthesis, properties, and biological activity of poly [di (sodium carboxylatoethylphenoxy) phosphazene] AK Andrianov, A Marin, J Chen Biomacromolecules 7 (1), 394-399, 2006 | 108 | 2006 |
| Poly (dichlorophosphazene) as a precursor for biologically active polyphosphazenes: Synthesis, characterization, and stabilization AK Andrianov, J Chen, MP LeGolvan Macromolecules 37 (2), 414-420, 2004 | 103 | 2004 |
| Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery LG Payne, SA Jenkins, A Andrianov, BE Roberts Vaccine design: the subunit and adjuvant approach, 473-493, 1995 | 94 | 1995 |
| Controlled release using ionotropic polyphosphazene hydrogels AK Andrianov, S Cohen, KB Visscher, LG Payne, HR Allcock, R Langer Journal of controlled release 27 (1), 69-77, 1993 | 90 | 1993 |
| Phosphazene polyelectrolytes as immunoadjuvants HR Allcock, AK Andrianov, RS Langer, KB Visscher US Patent 5,562,909, 1996 | 86 | 1996 |
| Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity JJ Steinhardt, J Guenaga, HL Turner, K McKee, MK Louder, S O’Dell, ... Nature communications 9 (1), 877, 2018 | 78 | 2018 |
| Hydrogel microencapsulated vaccines AK Andrianov, SA Jenkins, LG Payne, BE Roberts US Patent 5,529,777, 1996 | 78 | 1996 |
Robert LangerDavid H. Koch Institute Professor, MITE-mail confirmado em mit.edu
